Vildagliptin 50mg + Metformin 1000mg Tablet in PCD pharma franchise in Hyderabad

Vildagliptin 50mg + Metformin 1000mg Tablet in pharmaceutical manufacturing company in Mumbai

Vildagliptin 50mg + Metformin 1000mg Tablet in pharma franchise in Pune

Vildagliptin 50mg + Metformin 1000mg Tablet in pharma suppliers in Delhi

Vildagliptin 50mg + Metformin 1000mg Tablet in pharma export companies in Kolkata
Vildagliptin 50mg + Metformin 1000mg Tablet in pharma franchise opportunities in Bengaluru

Home/Products /vildagliptin-i-point-50mg-metformin-hcl-1000mg-tablets

Vlidaplit M Forte Tablet

Composition : Vildagliptin I.P. 50mg + Metformin HCL I.P. 1000mg Tablets

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*15

Price : ₹308/-

Validaplit M Forte Tablet is a potent combination of Vildagliptin 50mg and Metformin Hydrochloride 1000mg, formulated to manage type 2 diabetes mellitus effectively. Vildagliptin is a DPP-4 inhibitor that enhances the levels of incretin hormones, promoting increased insulin secretion and reduced glucagon release in a glucose-dependent manner. Metformin Hydrochloride, a biguanide, reduces hepatic glucose production and improves peripheral insulin sensitivity, thereby lowering blood glucose levels. Together, this combination provides complementary mechanisms of action that help achieve better glycemic control with a reduced risk of hypoglycemia. Validaplit M Forte supports improved insulin function and glucose metabolism, making it suitable for patients requiring intensified treatment alongside diet and exercise.

Read More

About the Product

Validaplit M Forte Tablet is a potent combination of Vildagliptin 50mg and Metformin Hydrochloride 1000mg, formulated to manage type 2 diabetes mellitus effectively. Vildagliptin is a DPP-4 inhibitor that enhances the levels of incretin hormones, promoting increased insulin secretion and reduced glucagon release in a glucose-dependent manner. Metformin Hydrochloride, a biguanide, reduces hepatic glucose production and improves peripheral insulin sensitivity, thereby lowering blood glucose levels. Together, this combination provides complementary mechanisms of action that help achieve better glycemic control with a reduced risk of hypoglycemia. Validaplit M Forte supports improved insulin function and glucose metabolism, making it suitable for patients requiring intensified treatment alongside diet and exercise.

Common side effects may include gastrointestinal discomfort such as nausea, vomiting, diarrhea, and abdominal pain, mostly due to Metformin. Vildagliptin is generally well tolerated but can cause headache or dizziness in some cases. Rarely, hypoglycemia may occur, particularly if used with other antidiabetic medications.

Indicated for the treatment of type 2 diabetes mellitus, especially when monotherapy with Metformin or Vildagliptin alone does not provide adequate glycemic control.

Not recommended for patients with type 1 diabetes, diabetic ketoacidosis, or severe renal impairment. Regular monitoring of blood glucose and renal function is advised. Use with caution in patients with liver disorders. Consult a healthcare professional before use during pregnancy or breastfeeding.

Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of the reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation